Clinical Trials Browser

Phase 1/2 × Rectal Neoplasms × dostarlimab × Clear all

NCT04926324 2025-06-29

A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers

Phase 1/2 Terminated

Gastrointestinal

Rectal Neoplasms